• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂谱在成人噬血细胞性淋巴组织细胞增生症中的预后价值。

Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis.

作者信息

Cheng Wanying, Wang Lingling, Gao Xin, Duan Limin, Shu Yongqian, Qiu Hongxia

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

出版信息

Front Oncol. 2023 Feb 21;13:1083088. doi: 10.3389/fonc.2023.1083088. eCollection 2023.

DOI:10.3389/fonc.2023.1083088
PMID:36895490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9988898/
Abstract

BACKGROUND

Adult secondary hemophagocytic lymphohistiocytosis (sHLH) is a rare clinical syndrome with a high mortality rate. Currently, there are no feasible prognostic factors to clinically predict untreated sHLH patients' prognosis. Our objective was to characterize the lipid profile of adult sHLH patients and to determine the relationship with overall survival.

METHODS

We retrospectively analyzed 247 patients with newly diagnosed sHLH from January 2017 to January 2022 according to the HLH-2004 criteria. Multivariate Cox regression analyses and restricted cubic splines were conducted to evaluate the prognostic value of the lipid profile.

RESULTS

The median age of all patients was 52 years, and the commonest cause of sHLH in our cohort was malignancy. During a median follow-up of 88 (interquartile ranges, 22-490) days, 154 deaths occurred. The univariate analysis confirmed total cholesterol (TC) ≤ 3 mmol/L, triglycerides (TG) > 3.08 mmol/L, high-density lipoprotein cholesterol (HDL-c) ≤ 0.52 mmol/L, and low-density lipoprotein cholesterol (LDL-c) ≤ 2.17 mmol/L were associated with an inferior survival. In a multivariate model, HDL-c, hemoglobin, platelet, fibrinogen, and soluble interleukin-2 receptor were considered as independent factors. Additionally, the restricted cubic spline analyses indicated an inverse linear association between HDL-c and the risk of mortality in sHLH.

CONCLUSION

Lipid profiles, which were low-cost and readily available promising biomarkers, were strongly associated with the overall survival in adult sHLH patients.

摘要

背景

成人继发性噬血细胞性淋巴组织细胞增生症(sHLH)是一种死亡率很高的罕见临床综合征。目前,尚无可行的预后因素能在临床上预测未经治疗的sHLH患者的预后。我们的目的是描述成人sHLH患者的血脂谱特征,并确定其与总生存期的关系。

方法

我们根据HLH-2004标准,回顾性分析了2017年1月至2022年1月期间247例新诊断的sHLH患者。进行多变量Cox回归分析和限制性立方样条分析以评估血脂谱的预后价值。

结果

所有患者的中位年龄为52岁,我们队列中sHLH最常见的病因是恶性肿瘤。在中位随访88(四分位间距,22 - 490)天期间,发生了154例死亡。单变量分析证实,总胆固醇(TC)≤3 mmol/L、甘油三酯(TG)> 3.08 mmol/L、高密度脂蛋白胆固醇(HDL-c)≤0.52 mmol/L和低密度脂蛋白胆固醇(LDL-c)≤2.17 mmol/L与较差的生存期相关。在多变量模型中,HDL-c、血红蛋白、血小板、纤维蛋白原和可溶性白细胞介素-2受体被视为独立因素。此外,限制性立方样条分析表明,HDL-c与sHLH患者的死亡风险之间存在负线性关联。

结论

血脂谱是低成本且易于获得的有前景的生物标志物,与成人sHLH患者的总生存期密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/fe5929050481/fonc-13-1083088-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/ed766e02a760/fonc-13-1083088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/0dfc48773689/fonc-13-1083088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/52cd974e599d/fonc-13-1083088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/257c94df00ee/fonc-13-1083088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/fe5929050481/fonc-13-1083088-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/ed766e02a760/fonc-13-1083088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/0dfc48773689/fonc-13-1083088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/52cd974e599d/fonc-13-1083088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/257c94df00ee/fonc-13-1083088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693d/9988898/fe5929050481/fonc-13-1083088-g005.jpg

相似文献

1
Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis.血脂谱在成人噬血细胞性淋巴组织细胞增生症中的预后价值。
Front Oncol. 2023 Feb 21;13:1083088. doi: 10.3389/fonc.2023.1083088. eCollection 2023.
2
The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis.血浆纤维蛋白原在成人继发性噬血细胞性淋巴组织细胞增生症中的预后作用。
Orphanet J Rare Dis. 2020 Nov 25;15(1):332. doi: 10.1186/s13023-020-01622-2.
3
Low total cholesterol predicts early death in children with hemophagocytic lymphohistiocytosis.低总胆固醇预示着噬血细胞性淋巴组织细胞增生症患儿的早期死亡。
Front Pediatr. 2023 Jan 9;10:1006817. doi: 10.3389/fped.2022.1006817. eCollection 2022.
4
Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.基于血液的炎症生物标志物在继发性噬血细胞性淋巴组织细胞增生症中的预后价值。
J Clin Immunol. 2020 Jul;40(5):718-728. doi: 10.1007/s10875-020-00801-x. Epub 2020 Jun 3.
5
Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis.血小板计数降低与成人继发性噬血细胞性淋巴组织细胞增生症患者不良生存相关。
Ann Hematol. 2024 Apr;103(4):1159-1166. doi: 10.1007/s00277-024-05663-6. Epub 2024 Feb 20.
6
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症早期死亡的危险因素和预后。
Ann Hematol. 2023 Sep;102(9):2301-2308. doi: 10.1007/s00277-023-05153-1. Epub 2023 Jun 2.
7
Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.严重 2019 冠状病毒病成年患者发生继发性噬血细胞性淋巴组织细胞增生症的危险因素。
BMC Infect Dis. 2021 Apr 29;21(1):398. doi: 10.1186/s12879-021-06094-8.
8
The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.AST/ALT(德瑞蒂斯)比值在成人继发性噬血细胞性淋巴组织细胞增生症患者中的预后作用。
Mediators Inflamm. 2020 Dec 5;2020:5719751. doi: 10.1155/2020/5719751. eCollection 2020.
9
[Analysis of High-Risk Clinical Factors of Early Death in Secondary Hemophagocytic Lymphohistiocytosis].[继发性噬血细胞性淋巴组织细胞增生症早期死亡的高危临床因素分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1866-1871. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.041.
10
Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome.47 例继发性噬血细胞性淋巴组织细胞增生症并发毛细血管渗漏综合征患者的临床特征。
Int J Hematol. 2021 Feb;113(2):263-270. doi: 10.1007/s12185-020-03011-8. Epub 2020 Oct 9.

引用本文的文献

1
Predicting Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients with Scrub Typhus and Its Prognostic Significance.预测成年恙虫病患者继发性噬血细胞性淋巴组织细胞增生症及其预后意义
Indian J Crit Care Med. 2024 Sep;28(9):823-831. doi: 10.5005/jp-journals-10071-24787. Epub 2024 Aug 31.
2
Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.利用机器学习技术早期识别系统性红斑狼疮继发的巨噬细胞活化综合征。
Arthritis Res Ther. 2024 May 9;26(1):92. doi: 10.1186/s13075-024-03330-9.
3
Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis.

本文引用的文献

1
Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis.脓毒症期间肝功能障碍、脂蛋白浓度与死亡率的关系。
PLoS One. 2022 Aug 22;17(8):e0272352. doi: 10.1371/journal.pone.0272352. eCollection 2022.
2
Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality.噬血细胞性淋巴组织细胞增生症患儿高甘油三酯血症和低纤维蛋白原血症的转归及多器官功能障碍综合征和早期死亡的风险。
Orphanet J Rare Dis. 2022 Apr 11;17(1):161. doi: 10.1186/s13023-022-02315-8.
3
Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 227 Cases.
继发性噬血细胞性淋巴组织细胞增生症免疫失调的综合评估。
Virulence. 2024 Dec;15(1):2342276. doi: 10.1080/21505594.2024.2342276. Epub 2024 Apr 17.
儿童噬血细胞性淋巴组织细胞增生症的临床特征和预后因素:227 例回顾性分析。
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e217-e222. doi: 10.1097/MPH.0000000000002283.
4
Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.脓毒症后脂蛋白和胆固醇改变的持续存在:对动脉粥样硬化进展的影响。
Int J Mol Sci. 2021 Sep 29;22(19):10517. doi: 10.3390/ijms221910517.
5
Relationship between lipoprotein concentrations and short-term and 1-year mortality in intensive care unit septic patients: results from the HIGHSEPS study.重症监护病房脓毒症患者脂蛋白浓度与短期及1年死亡率的关系:HIGHSEPS研究结果
Ann Intensive Care. 2021 Jan 19;11(1):11. doi: 10.1186/s13613-021-00800-0.
6
Outcomes and prognostic factors associated with 180-day mortality in Taiwanese pediatric patients with Hemophagocytic Lymphohistiocytosis.台湾地区噬血细胞性淋巴组织细胞增生症儿科患者 180 天死亡率的相关结局和预后因素。
J Formos Med Assoc. 2021 Apr;120(4):1061-1068. doi: 10.1016/j.jfma.2020.10.026. Epub 2020 Nov 17.
7
Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure.基于血脂蛋白的列线图预测乙型肝炎病毒相关慢加急性肝衰竭患者的死亡率。
BMC Gastroenterol. 2020 Jun 15;20(1):188. doi: 10.1186/s12876-020-01324-w.
8
Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome.早期血液净化在重症 EBV 相关性噬血细胞综合征中的应用。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2019-3197. Epub 2020 May 19.
9
Hypolipidemia is associated with the severity of COVID-19.血脂异常与 COVID-19 的严重程度有关。
J Clin Lipidol. 2020 May-Jun;14(3):297-304. doi: 10.1016/j.jacl.2020.04.008. Epub 2020 Apr 30.
10
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.噬血细胞性淋巴组织细胞增生症:发病机制、诊断和治疗的最新进展。
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101515. doi: 10.1016/j.berh.2020.101515. Epub 2020 May 7.